Quantitation of glial fibrillary acidic protein in human brain tumours

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Quantitation of glial fibrillary acidic protein in human brain tumours. / Rasmussen, S; Bock, E; Warecka, K; Althage, G.

In: British Journal of Cancer, Vol. 41, No. 1, 1980, p. 113-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Rasmussen, S, Bock, E, Warecka, K & Althage, G 1980, 'Quantitation of glial fibrillary acidic protein in human brain tumours', British Journal of Cancer, vol. 41, no. 1, pp. 113-6.

APA

Rasmussen, S., Bock, E., Warecka, K., & Althage, G. (1980). Quantitation of glial fibrillary acidic protein in human brain tumours. British Journal of Cancer, 41(1), 113-6.

Vancouver

Rasmussen S, Bock E, Warecka K, Althage G. Quantitation of glial fibrillary acidic protein in human brain tumours. British Journal of Cancer. 1980;41(1):113-6.

Author

Rasmussen, S ; Bock, E ; Warecka, K ; Althage, G. / Quantitation of glial fibrillary acidic protein in human brain tumours. In: British Journal of Cancer. 1980 ; Vol. 41, No. 1. pp. 113-6.

Bibtex

@article{81554310b1c011df825b000ea68e967b,
title = "Quantitation of glial fibrillary acidic protein in human brain tumours",
abstract = "The glial fibrillary acidic protein (GFA) content of 58 human brain tumours was determined by quantitative immunoelectrophoresis, using monospecific antibody against GFA. Astrocytomas, glioblastomas, oligodendrogliomas, spongioblastomas, ependymomas and medulloblastomas contained relatively high amounts of GFA, up to 85 times the concentration in parietal grey substance of normal human brain. GFA was not found in neurinomas, meningiomas, adenomas of the hypophysis, or in a single case of metastasis of adenocarcinoma. Non-glial tumours of craniopharyngioma and haemangioblastoma were infiltrated by reactive astroglia and showed considerable amounts of GFA.",
author = "S Rasmussen and E Bock and K Warecka and G Althage",
note = "Keywords: Albumins; Brain Neoplasms; Glioma; Humans; Immunoelectrophoresis; Neoplasm Proteins",
year = "1980",
language = "English",
volume = "41",
pages = "113--6",
journal = "The British journal of cancer. Supplement",
issn = "0007-0920",
publisher = "nature publishing group",
number = "1",

}

RIS

TY - JOUR

T1 - Quantitation of glial fibrillary acidic protein in human brain tumours

AU - Rasmussen, S

AU - Bock, E

AU - Warecka, K

AU - Althage, G

N1 - Keywords: Albumins; Brain Neoplasms; Glioma; Humans; Immunoelectrophoresis; Neoplasm Proteins

PY - 1980

Y1 - 1980

N2 - The glial fibrillary acidic protein (GFA) content of 58 human brain tumours was determined by quantitative immunoelectrophoresis, using monospecific antibody against GFA. Astrocytomas, glioblastomas, oligodendrogliomas, spongioblastomas, ependymomas and medulloblastomas contained relatively high amounts of GFA, up to 85 times the concentration in parietal grey substance of normal human brain. GFA was not found in neurinomas, meningiomas, adenomas of the hypophysis, or in a single case of metastasis of adenocarcinoma. Non-glial tumours of craniopharyngioma and haemangioblastoma were infiltrated by reactive astroglia and showed considerable amounts of GFA.

AB - The glial fibrillary acidic protein (GFA) content of 58 human brain tumours was determined by quantitative immunoelectrophoresis, using monospecific antibody against GFA. Astrocytomas, glioblastomas, oligodendrogliomas, spongioblastomas, ependymomas and medulloblastomas contained relatively high amounts of GFA, up to 85 times the concentration in parietal grey substance of normal human brain. GFA was not found in neurinomas, meningiomas, adenomas of the hypophysis, or in a single case of metastasis of adenocarcinoma. Non-glial tumours of craniopharyngioma and haemangioblastoma were infiltrated by reactive astroglia and showed considerable amounts of GFA.

M3 - Journal article

C2 - 7362772

VL - 41

SP - 113

EP - 116

JO - The British journal of cancer. Supplement

JF - The British journal of cancer. Supplement

SN - 0007-0920

IS - 1

ER -

ID: 21607599